ArticleFrontiers in neurology2025
Safety and efficacy of percutaneous radiofrequency thermocoagulation with varying puncture trajectories for recurrent maxillary trigeminal neuralgia: a prospective study.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Advanced, pharmacological and complementary interventions for chronic or recurrent orofacial pain conditions: a systematic evidence map with selective meta-analyses.The journal of headache and pain · 2026Pooled it
- [Novel framework based on multi-stage random sampling and differentiable rendering for automated three-dimensional orientation estimation of skull base foramina].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Recurrence of maxillary trigeminal neuralgia (TN) poses a significant clinical challenge. Percutaneous radiofrequency thermocoagulation (PRT) has been established as an effective treatment for maxillary TN. However, the safety and efficacy of different puncture pathways, particularly in the context of pain recurrence, may vary. Objective: This study aimed to compare the safety and efficacy of PRT via the foramen ovale (FO) and pterygopalatine fossa (PF) approaches for recurrent maxillary TN. Methods: This prospective, non-randomized controlled study included 46 patients with recurrent maxillary TN who underwent PRT at our hospital between January 2021 and June 2021. Patients were divided into two groups based on the puncture pathway: the FO group and the PF group. All procedures were performed under local anesthesia and guided by computed tomography (CT). Operative complications were monitored, and pain was assessed using the Visual Analog Scale (VAS) and the Barrow Neurological Institute (BNI) scale. Follow-up evaluations were conducted at 6, 12, 18, and 24 months postoperatively. Results: The efficacy rates of the two puncture pathways within 24 months were 69.5% (FO group) and 78.2% (PF group), respectively. All patients experienced hypoesthesia in the maxillary nerve area. No severe complications, such as blindness, intracranial hemorrhage, or intracranial infection, were observed in either group. Conclusion: Both the FO and PF puncture pathways for PRT are safe and effective for treating recurrent maxillary TN. However, for patients with a history of prior PRT or percutaneous balloon compression (PBC) targeting the Gasserian ganglion, the PF approach may be preferable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.